of tendon reconstructing using mouse E-CEL TEC (Tendon Endothelial Cells). We would like to apprise you on further details. As you might know from Jeff P, we have kicked off an institutional Series B funding during the JP Morgan HC week (Jan 2016 in San Francisco). Our target is $10- 20M capital raise